Literature DB >> 6572570

Electrocardiogram abnormalities induced by amsacrine.

R B Weiss, D Moquin, J D Adams, J D Griffin, H Zimbler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6572570     DOI： 10.1007/bf00446226

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN： 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  9 in total

Review 1.  Electrophysiology and pharmacology of cardiac arrhythmias. vii. Cardiac effects of quinidine and procaine amide. B.

Authors:  B F Hoffman; M R Rosen; A L Wit
Journal:  Am Heart J       Date:  1975-07       Impact factor: 4.749

Review 2.  Q-T interval syndromes.

Authors:  G M Vincent; J A Abildskov; M J Burgess
Journal:  Prog Cardiovasc Dis       Date:  1974 May-Jun       Impact factor: 8.194

3.  Ventricular fibrillation, hypokalemia, and AMSA therapy.

Authors:  J A Foldes; Y Yagil; A Kornberg
Journal:  Ann Intern Med       Date:  1982-01       Impact factor: 25.391

4.  Quinidine-induced ventricular flutter and fibrillation without digitalis therapy.

Authors:  R W Koster; H J Wellens
Journal:  Am J Cardiol       Date:  1976-10       Impact factor: 2.778

5.  m-AMSA: an exciting new drug in the National Cancer Institute Drug Development Program.

Authors:  R B Weiss; L M Charles; J S Macdonald
Journal:  Cancer Clin Trials       Date:  1980

6.  Multiple ventricular extrasystoles following administration of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA).

Authors:  G Falkson
Journal:  Cancer Treat Rep       Date:  1980 Feb-Mar

7.  Neurologic and cardiac rhythm abnormalities associated with 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) therapy.

Authors:  S S Legha; J Latreille; K B McCredie; G P Bodey
Journal:  Cancer Treat Rep       Date:  1979 Nov-Dec

8.  Cardiac abnormalities after AMSA administration.

Authors:  L J Steinherz; P G Steinherz; D Mangiacasale; C Tan; D R Miller
Journal:  Cancer Treat Rep       Date:  1982-03

9.  Acute ventricular fibrillation and death during infusion of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA).

Authors:  D D Von Hoff; D Elson; G Polk; C Coltman
Journal:  Cancer Treat Rep       Date:  1980 Feb-Mar
  9 in total
  2 in total

Review 1.  Cardiotoxicity of cancer chemotherapy: implications for children.

Authors:  Valeriano C Simbre; Sarah A Duffy; Gul H Dadlani; Tracie L Miller; Steven E Lipshultz
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

2.  Treatment of acute leukaemia with m-AMSA in combination with cytosine arabinoside.

Authors:  H S Dhaliwal; M S Shannon; M J Barnett; H G Prentice; K Bragman; J S Malpas; T A Lister
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.